Recent Finacing
Recent Raise
Allinaire Therapeutics develops disease‑modifying therapeutics for pulmonary disorders (AAT deficiency, COPD, emphysema, acute lung injury) by targeting specific secreted proteins to reduce pathological activity.
Focus Areas
Recent Investors
Funding round
Investors
